The Ekhaga Foundation, Stockholm, Sweden   Report issue

Foundation Phase 2
Founded: Stockholm Sweden (1999)

Organization Overview

First Clinical Trial
2001
NCT01285830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Ekhaga foundation | The Ekhaga Foundation, Sweden

Active Ingredients

Drugs in Phase 2 Trials (1)

lactobacillus reuteri (2 trials)

Drugs in Other Trials (3)

icosapent ethyl (vascepa) (1 trial)

soybean oil (1 trial)

zhineng qigong (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 2)

Enterocolitis (Phase 2)

Enterocolitis, Necrotizing (Phase 2)

Failure to Thrive (Phase 2)

Premature Birth (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4